- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2008
- Public Summary Document (PSD) July 2008 PBAC Meeting - PDF
Eculizumab – July 2008
Eculizumab, solution concentrate for I.V. infusion, 300 mg in 30 mL, Soliris®, July 2008
Last updated
14 November 2008